Dr. Peter Hanson

Institute of Cellular Medicine
Medical Toxicology Centre Newcastle University
United Kingdom

Scientist Neurology
Biography

Dr. Peter Hanson is currently working as a Research Associate in the Medical Toxicology Centre, Newcastle University , United Kingdom. His research interests include Neurodegenerative disorders, Neurodevelopmental exposure determination, Human induced pluripotent stem cell derived toxicology assays. He is serving as an editorial member and reviewer in several international reputed journals. He is a member of many international affiliations. He has successfully completed his Administrative responsibilities. He has authored many research articles related to his Research interest.

Research Intrest

Neurodegenerative disorders, Neurodevelopmental exposure determination, Human induced pluripotent stem cell derived toxicology assays.

List of Publications
Ishaq A, Hanson PS, Morris CM, Saretzki G. Telomerase Activity is Downregulated Early During Human Brain Development. Genes 2016, 7(6), 27.
Hanson PS, Matthias K, Tsefou E, Thomas SLH, Blain PG, Morris CM. Neurotoxicity of novel psychoactive substances. In: British Toxicology Annual Congress 2016. 2016, Manchester, UK. Ishaq A, Hanson PS, Morris CM, Saretzki G. Telomerase Activity is Downregulated Early During Human Brain Development. Genes 2016, 7(6), 27.
Singh P, Hanson PS, Morris CM. SIRT1 ameliorates oxidative stress induced neural cell death and is down-regulated in Parkinson’s disease. BMC Neuroscience 2017, 18(1), 46.